Skip to content
★ Sign in to follow
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€226k

Latest filing published 25 Nov 2011 for Lineage Cell Therapeutics, Inc., €18k.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

Judith Segall: trading record in brief

Judith Segall discloses dealings in Lineage Cell Therapeutics, Inc. to SEC (Form 4). We count 15 filings; the first trade dates from 28 May 2009 and the latest from 22 November 2011.

On the market, this insider has only sold: 7 sales, €226k in total. Other entries cover 4 share grants and 4 option exercises.

The latest filing, published on 25 November 2011, reports a share grant of €18k in Lineage Cell Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Judith Segall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations